4.5 Article

Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment

Related references

Note: Only part of the references are listed.
Article Oncology

A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti-PD-L1 mAb Combination to Enhance the Antitumor Effect

Xuejun Wen et al.

Summary: This study found the potential of positron emission tomography tracer 2[F-18]FDG as an immunomodulator, inducing changes in PD-L1 expression and creating an immune-favorable microenvironment for tumor immunotherapy. The experimental results showed that the 2[F-18]FDG-based immunotherapy regimen could improve the utilization rate of anti-PD-L1 monoclonal antibodies, significantly delay tumor growth, and transform low immunoactivity tumors into hot tumors sensitive to ICB therapy.

CLINICAL CANCER RESEARCH (2022)

Article Multidisciplinary Sciences

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment

Moataz Reda et al.

Summary: Immune checkpoint inhibitors have limited response rates in non-small cell lung cancer (NSCLC), and this study presents a nanoparticle-based immunotherapy that co-delivers a PLK1 inhibitor and PD-L1 antibody, showing anti-tumor immune responses in preclinical lung cancer models.

NATURE COMMUNICATIONS (2022)

Review Oncology

Cytotoxic CD8+T cells in cancer and cancer immunotherapy

Hans Raskov et al.

Summary: The functions and interactions between the innate and adaptive immune systems play a crucial role in anticancer immunity. Cytotoxic T cells with CD8 as the most effective effectors in the anticancer immune response form the basis of successful cancer immunotherapies. Advancements in genetically modified or synthetic receptors on cytotoxic T cells are being developed for future cancer treatment. Combinatory regimens may optimize treatment effects and reduce adverse events in cancer therapy.

BRITISH JOURNAL OF CANCER (2021)

Article Engineering, Biomedical

Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

Wenxi Zhou et al.

Summary: The study demonstrates a dual delivery biosystem based on exosomes for enhancing PDAC immunotherapy and reversing tumor immunosuppression. By disrupting the galectin-9/dectin 1 axis, the system can improve drug accumulation in the tumor site and elicit anti-tumor immune response.

BIOMATERIALS (2021)

Review Oncology

Macrophage-Based Approaches for Cancer Immunotherapy

Nicholas R. Anderson et al.

Summary: Adoptive cell therapy with genetically modified T cells has shown promising results in hematologic malignancies, but applying it to solid tumors has been challenging. This has led to the investigation of alternative immune cells as therapeutic options. Macrophages have functional plasticity that can be harnessed for both antitumor and protumor effects, leading to efforts to deplete or repolarize tumor-associated macrophages, as well as exploring the potential of adoptively transferring genetically modified macrophages.

CANCER RESEARCH (2021)

Article Chemistry, Multidisciplinary

Combination Chemo-Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti-PD-1

Xiangsheng Liu et al.

Summary: Improving irinotecan delivery using a lipid bilayer coated mesoporous silica nanoparticle, known as a silicasome, can enhance PDAC survival through a chemo-immunotherapy response in a Kras-dependent pancreatic cancer model. This method triggers a cascade of events including autophagy inhibition, endoplasmic reticulum stress, immunogenic cell death (ICD), and PD-L1 expression. The chemo-immunotherapy response elicited by the silicasome is more robust than traditional drug delivery methods and can be synergistically enhanced with anti-PD-1 therapy.

ADVANCED SCIENCE (2021)

Article Engineering, Biomedical

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy

Jinsheng Huang et al.

Summary: A novel nanocarrier was developed for tumor-targeted delivery in melanoma to activate anti-tumor immunity and reduce adverse effects. Additionally, combining sonodynamic therapy with immunotherapy effectively promotes anti-cancer immunity and suppresses melanoma growth.

BIOMATERIALS (2021)

Article Multidisciplinary Sciences

A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting

Yanmei He et al.

Summary: By developing cascade-targeting, dual drug-loaded core-shell nanoparticles, precise drug delivery to tumors and overcoming biological barriers were achieved; the degradation of hyaluronic acid shell facilitated drug release and cellular uptake, while the exposure of triphenylphosphonium derivative core allowed for mitochondria-targeted delivery, ultimately inhibiting tumor growth.

SCIENCE ADVANCES (2021)

Article Nanoscience & Nanotechnology

Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy

Xiaqing Wu et al.

Summary: The study utilized hollow Fe3O4 nanoparticles to reprogram TAMs towards M1 phenotype, activating antitumor immune responses and releasing nitric oxide for synergistic therapy against cancer.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Chemistry, Multidisciplinary

Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy

Baicheng Wei et al.

Summary: A new cancer treatment strategy has been developed, where tumor-associated macrophage polarization therapy combined with ICD induced by low-dose chemotherapy drugs can significantly enhance the efficacy of immunotherapy.

NANO LETTERS (2021)

Article Biotechnology & Applied Microbiology

Ultrasound targeted microbubble destruction combined with Fe-MOF based bio-/enzyme-mimics nanoparticles for treating of cancer

Xi Xiang et al.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Chemistry, Multidisciplinary

Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy

DaeYong Lee et al.

Summary: The discovery of immune checkpoint blockade has revolutionized cancer treatment, but current immunotherapies are only effective for a small subset of patients. Future advancements in cancer immunotherapy will focus on developing novel therapeutic molecules or immunoengineered cells. Biomaterials can efficiently reprogram and recruit immune cells in tumors to activate T cell immunity against advanced cancers.

ADVANCED MATERIALS (2021)

Article Engineering, Biomedical

Dual mitigation of immunosuppression combined with photothermal inhibition for highly effective primary tumor and metastases therapy

Ju Huang et al.

Summary: This study introduces a novel immunotherapeutic strategy utilizing a specific nanoliposome combining photothermal therapy with immune induction methods to enhance immune response, reduce inhibitory factors, and effectively combat cancer.

BIOMATERIALS (2021)

Article Immunology

Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells

Sho Hangai et al.

Summary: Cell death in cancer therapies is often associated with immunogenicity, but the study by Taniguchi and colleagues reveals that release of TCTP following cell death triggers an immunosuppressive pathway in the tumor microenvironment. Inhibiting TCTP can suppress MDSC accumulation and tumor growth, offering a new rationale for cancer immunotherapy. The study provides a better understanding of the dynamics in MDSC accumulation in the tumor microenvironment, with implications for developing new cancer therapeutics.

NATURE IMMUNOLOGY (2021)

Article Chemistry, Multidisciplinary

Ultrasound-Targeted Microbubble Destruction Mediates Gene Transfection for Beta-Cell Regeneration and Glucose Regulation

Chao Zhang et al.

Summary: The study demonstrated successful gene delivery of GLP-1 in macaques using UTMD, leading to enhanced GLP-1 expression and improvement in pancreatic beta cell regeneration and plasma glucose regulation. This approach shows promising alternatives for treating type 2 diabetes.

SMALL (2021)

Article Multidisciplinary Sciences

Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses

Zhijuan Yang et al.

Summary: The study presents a novel nanoreactor that enhances the effectiveness of RFA on tumors by suppressing residual tumors and promoting anti-tumor immunity in experimental models.

NATURE COMMUNICATIONS (2021)

Article Chemistry, Multidisciplinary

Overcoming Chemoimmunotherapy-Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension

Seung Mo Jin et al.

Summary: A novel immune modulating suspension containing inducers of cell death and supra-adjuvants can effectively increase cytotoxic T lymphocytes and alleviate immune suppression in the tumor microenvironment, leading to enhanced T cell infiltration and inhibition of tumor metastasis. This approach shows promise in increasing the response rate of immune checkpoint blockade therapy, presenting a new nanotheranostic strategy in cancer immunotherapy.

ADVANCED SCIENCE (2021)

Review Oncology

Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies

Hiroyoshi Nishikawa et al.

Summary: With the widespread use of immunotherapies in cancer treatment, understanding the immune landscape in the tumor microenvironment has become crucial. Regulatory T cells (Tregs) play a key role in cancer immunity but also contribute to immune evasion by tumor cells. Targeting Tregs is considered a crucial aspect of cancer immunotherapy, especially in tumors with abundant Treg presence.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Medicine, Research & Experimental

Turning cold tumors into hot tumors by improving T-cell infiltration

Yuan-Tong Liu et al.

Summary: Immunotherapy, particularly through immune checkpoint inhibitors, has significantly improved the treatment of malignant tumors by enhancing T cell infiltration into tumors. Understanding the mechanisms underlying cold tumors, which lack T cell infiltration, is crucial to improving immunotherapy efficacy. Strategies to transform cold tumors into hot tumors and increase T cell infiltration are discussed, along with the potential of nanomedicines in enhancing tumor immunotherapy.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors

Qingbo Xu et al.

Summary: The manganese porphyrin-based metal-organic framework (Mn-MOF) demonstrates great potential in enhancing cancer therapy through sonodynamic therapy and ferroptosis, showing strong anticancer activity and antitumor immunity in hypoxic tumors.

THERANOSTICS (2021)

Article Chemistry, Multidisciplinary

Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo

Jennifer C. Wischhusen et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Review Engineering, Biomedical

Immunoadjuvants for cancer immunotherapy: A review of recent developments

Asmita Banstola et al.

ACTA BIOMATERIALIA (2020)

Article Chemistry, Multidisciplinary

A Graphdiyne Oxide-Based Iron Sponge with Photothermally Enhanced Tumor-Specific Fenton Chemistry

Huan Min et al.

ADVANCED MATERIALS (2020)

Review Chemistry, Multidisciplinary

Multifunctional sonosensitizers in sonodynamic cancer therapy

Subin Son et al.

CHEMICAL SOCIETY REVIEWS (2020)

Article Chemistry, Multidisciplinary

Sonoporation of Cells by a Parallel Stable Cavitation Microbubble Array

Long Meng et al.

ADVANCED SCIENCE (2019)

Review Pharmacology & Pharmacy

Recent progress in drug delivery

Chong Li et al.

ACTA PHARMACEUTICA SINICA B (2019)

Article Chemistry, Multidisciplinary

Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy

Qian Chen et al.

ADVANCED MATERIALS (2019)

Article Oncology

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

Dal Fukurnura et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Multidisciplinary Sciences

Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist

Tadashi Hosoya et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Biochemistry & Molecular Biology

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Ming Yi et al.

MOLECULAR CANCER (2018)

Review Cell Biology

Dendritic cell-based immunotherapy

Rachel L. Sabado et al.

CELL RESEARCH (2017)

Editorial Material Medicine, Research & Experimental

Cancer immunotherapy: harnessing the immune system to battle cancer

Yiping Yang

JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Pharmacology & Pharmacy

Microbubbles in ultrasound-triggered drug and gene delivery

Sophie Hernot et al.

ADVANCED DRUG DELIVERY REVIEWS (2008)

Review Medicine, General & Internal

Metastasis: recent discoveries and novel treatment strategies

Suzanne A. Eccles et al.

LANCET (2007)